Skip to content or footer

The Company

Scotmas is a leading manufacturer of water treatment, hygiene and environmental care products. Best known for its extensive range of chlorine dioxide systems, developed with over 25 years experience in the market, it is now actively involved in developing microbial biotechnology, insect repellents, insecticidal textiles and consumer product ingredients.

With a strong and continued commitment to R&D, Scotmas is always on the look-out for strategic investment opportunities with other companies and projects which can provide experience and capabilities that will add value to its offering.

The Business Challenge

An introduction to Interface – The knowledge connection for business, presented an opportunity to advance two research projects, one looking at bacteria identification and another on bacteria and virus tests. Following an extensive search of expertise in the field, Interface helped the company to develop active partnerships with several academic institutions.

The company produces microbe-based products used for a variety of applications in waste water treatment and land remediation, but wanted to expand this into a range of domestic cleaners and products for specific industrial contamination.

The Solution

Following discussions with the University of Aberdeen, it was learnt that spin out company NCIMB was undertaking the characterisation of the bacteria strains on a routine basis.

Scotmas was looking for help to investigate the effectiveness of one of its products for a client. Interface facilitated a project with Glasgow Caledonian University’s Dr Chris Woodall, from the School of Life Sciences, offering specialist testing services for bacteriological and viral testing. The project resulted in a continued relationship and subsequent testing work.

Following the success of the initial project, Scotmas embarked on a number of new collaborative projects, including corrosion studies and a project on microencapsulation and was in active discussions with other academic groups including Scottish Crop Research Institute and the University of Glasgow.

Benefits

Alistair Cameron, Technical Director at Scotmas commented:

“We were looking to strengthen our range of microbe-based products in a variety of domestic cleaners and products for tackling specific industrial contamination.  Interface linked us to academic partners who helped in the commercial culturing of these microbes, in order to supply a powdered product to Scotmas’s commercial operations.”

Scotmas went on to collaborate with the engineering department at Heriot Watt University, an academic team that were included in the University’s research submission to REF 2014* (Research Excellence Framework), 94% of which was judged as “world-leading” or internationally excellent. 

In November 2016 Scotmas announced that they are sending new self-sustaining technology to Botswana to bring properly treated water supplies to some of its most remote areas.The Bravo Hydro system runs without grid electricity or solar power, using a tiny generator in the water pipe. Scotmas said the technology could bring reliably disinfected water to areas where it had not been possible before.It is being sent to 40 villages in Botswana thanks to a major investment by the country’s government. ​

Scotmas undertook around ten collaborative projects with academia since the original project facilitated by Interface including two Knowledge Transfer Partnerships (KTPs) with Heriot-Watt University. The family business employs 42 people and provides chlorine dioxide water solutions around the world – including in Doha for the Qatar World Cup 2022 and in villages in southern India.

In 2020 Interface linked Scotmas to Robert Gordon University to support the development of a new and innovative method of producing disinfectants without harmful by-products for use in hospitals, water supplies and food production applications. The project was funded through an Advanced Innovation Voucher and won Innovation of the Year at The Scottsh Knowledge Exchange Awards 2021.

*The REF is the system for assessing the quality of research in UK higher education institutions.

he Company

StudioLR is an award-winning design agency based in Leith, Edinburgh.

The Business Challenge

Dissatisfied with existing ‘way-finding’ products for dementia, and sensing an opportunity for a fresh and novel approach, the company wanted to access Scotland’s academic expertise to use the latest research to inform their design, ensuring an effective, as well as an attractive, finished product.

The Solution

After meeting at an industry event, Interface was able to identify extensive research expertise in the care of people with dementia at the universities of Edinburgh and Stirling, and introduced both universities to StudioLR.  After discussions with both universities, it was agreed that a collaborative approach to the project would be the best solution to provide the company with access to the most wide-ranging expertise.  A Scottish Funding Council Innovation Voucher, administered by Interface, was awarded to support this project.

Benefits

As a result of this successful business-academic collaboration, StudioLR developed a set of design guidelines for creating consistent signage to increase independence and wellbeing for older people and dementia patients in care homes, hospitals or other related environments.  Lucy Richards, Creative Director at StudioLR, said: 

“The collaborative process we have experienced working together with the universities of Edinburgh and Stirling on the Innovation Voucher has been both stimulating and fruitful, with exciting new thinking emerging throughout the process.  As the project builds in momentum, our purpose has become clearer and more worthwhile.”

Follow-on Activity

Following further brokerage services from Interface, StudioLR have been accepted into The Scottish Graduate School for Arts and Humanities (SGSAH) Doctoral Internship programme, which matches doctoral researchers with industry partners. The company are keen to establish research in the area of “impact and consequences of the use of complex language in everyday settings”, particularly in the Care system and across public services, i.e. in hospital and clinical settings.

The outputs from the researcher will be a report outlining key findings and recommendations on the unintended consequences and negative impact of the use of this language.

Please note that Interface administers the Innovation Voucher Scheme on behalf of the Scottish Funding Council. All funding applications are reviewed on a case by case basis by the Scottish Funding Council, guidelines can be found here.

React2 is a specialist software company based in Peebles, developing speech and language therapy rehabilitation tools for both adults and children suffering from brain injury and trauma.

Since 1998, the company has developed a suite of speech and language therapy (SLT) software called React, which has been a leading product for SLT, sold to therapists and private individuals throughout most English speaking countries.
 

The Business Challenge

React2 recognised the need to investigate, for the first time, the mechanisms underlying stroke patient recovery using computer assisted home therapy. This led to their Managing Director, Dean Turnbull, meeting with Dr Siobhán Jordan of Interface and the Knowledge Links team to investigate how the academic sector could support the development of the young business and to take forward the ideas of React2.

The Solution

The result has been a successful collaboration with SINAPSE, the Scottish university research pool for brain imaging. The research is being undertaken at the Brain Research Imaging Centre (BRIC), a member of the SINAPSE collaboration, at the Division of Clinical Neurosciences, University of Edinburgh at the Western General Hospital.

The project is investigating the patient recovery through leading edge functional Magnetic Resonance Imaging (fMRI). The academic alliance injected fresh, new approaches to the business and may lead to further developments of the React2 software, which contains a vast number of new exercises in an easy-to-use and up-to-date interface, and is a huge step forward in computer based therapy. The React2 development has combined the development skills of NHS speech and language therapists, as well as specialists from around the world.

PhD student and speech therapist, Anna Jones, who is leading the research, comments: “The results will assess the overall effectiveness of Speech and Language Therapy (SLT) and its long-term benefits. ‘React2’ could dramatically improve SLT for many stroke patients, allowing for more intensive therapy than is currently available.”

React2 sees the potential in e-health as the way forward for patient care.

Managing Director, Dean Turnbull, is thrilled by the collaboration: “This is the sort of research that we as a small company could never fund ourselves, but through Interface and SINAPSE, we are working with the foremost brain imaging specialists in the world. It’s fantastic.”

A 3 year studentship, part of the Knowledge Exchange in Translational Imaging grant funding from Scottish Funding Council to SINPASE, will take the research forward, and the next step of the project will investigate the long term mechanisms underlying stroke patient recovery using computer assisted home therapy and will investigate the patient recovery through leading edge fMRI imaging. This will involve the University of Edinburgh’s Brain Imaging Research Centre at the Western General Hospital’s Division of Clinical Neurosciences. Dean believes that this will result in significant business growth, with increased sales and new employment within the company.

“We are delighted that the collaboration between Propeller Media and University of Edinburgh, facilitated by Interface. Importantly, this relationship highlights how SME’s can benefit from expertise available”. Siobhan Jordan, Director of Interface

One of the UK’s leading salt traders, Peacock Salt, turned to Scotland’s academic sector to help in the technical challenge of designing a new, natural, green and economically viable method to make (sea) salt domestically.

Initially a shipping company, J C Peacock & Co Ltd is a small family business based in Ayr, which was established in 1874, evolving into a salt trading firm. Peacock salts are used for general de-icing and water softening properties as well as for industrial use in the food, agriculture, cosmetic and pharmaceutical industries.

Keen to investigate salt production in Scotland, the company met with Interface – the knowledge connection for business – to help source an academic partner that could provide the right mix of experience required for the project. 

With help from Interface, Peacock Salt was able to connect with Dr Carl Schaschke from the University of Strathclyde’s Department of Chemical and Process Engineering.  Dr Schaschke had experience with natural salt production methods, such as purification of brine from volcanic craters and solar evaporation.

The Business Challenge

Earlier methods of making salt in Scotland were uneconomical; therefore Peacock was keen to lead the way in developing a new, industry-leading method.  Ultimately, they envisaged a new salt production plant being built – similar to innovative new plants in other parts of the world, such as Bad Salzuflen in Germany.

The main challenge in production terms was turning sea water (ca. 3% saline solution) into a concentrated solution of ca. 26%, which is when salt crystals start to drop out of solution.  The quality of the crystals is affected by the latter stages of the evaporation procedure. 

Peacock Salt offers the largest variety of salts available in the UK.  With over 6,000 customers, the company’s range includes salts from around the world such as Rock, Sea and Manufactured salts. 

Peacock Salt’s operations manager, Gregorie Marshall, was keen that the process used as natural a method as possible:  “Ideally we wanted to develop a salt production process that used green energy, where little additional input of heat and electricity is required, while also developing a new plant which itself would become a tourist attraction.

“We needed expertise in the areas of chemistry, chemical technology, chemical or process engineering to carry out research which would investigate and design the most suitable method of producing salt in Scotland. We also wanted to identify and analyse suitable sites using geographical and meteorological data.” 

Three universities came forward as potential partners for the project but ultimately, Peacock Salt chose to move forward with Strathclyde as Dr Schaschke had direct experience in salt production.

Initial discussions were leaning towards taking the project on as a Knowledge Transfer Partnership (KTP), however it was decided that an initial financial feasibility study was required before progressing the KTP.  

The Solution

Peacock Salt was introduced to Carrie Shaw from the Strathclyde Links project, who was able to assist the firm source funding for the feasibility study, which was completed by Professor John Finch, of the University of Strathclyde Business School’s Department of Marketing.

Professor Finch, working with PhD student Emma Reid, provided Peacock Salt with a market/business viability report that provided in-depth analysis of the market for a sea salt produced at a facility in Scotland, including developing business scenarios in order to assess product positioning, price and current competitors in the market place.

A KTP to investigate a Scottish salt production facility took place in 2011.

Follow On activity

Following this successful project, Peacock Salt got back in touch with Interface to seek an academic partner to develop chemical brine which would allow them to extend their current offering of liquid de-icer.

This required the development of an additive that lowers the freezing point of the brine, and therefore the working temperature of the de-icer, without having any detrimental impact on the handling of the material. The additive would also enhance the salt or brine’s ability to adhere to the surface it has been applied to, offering a longer residual effect whilst not impairing the de-icing capabilities.

Interface successfully matched Peacock with Dr Mohammed Yaseen and Professor Andrew Hursthouse from the University of the West of Scotland to lead on this project. The team investigated the additives that can be applied to de-icers and examined performance improvements such as freeze-point suppression, reduced environmental impact and increased residual effect.

As a result, this would deliver an enhanced product offering for the business in the relatively innovation-free winter maintenance market. It will also have a positive impact on the business operating in the UK and potentially open up new market opportunities further field.

In addition, Peacock Salt is currently working on another collaboration project facilitated by Interface. 

As a key supplier of de-icing salt and winter equipment to local authorities, businesses and private individuals, Peacock Salt were keen to tackle another industry challenge. During winter, de-icer salt is spread on the roads every day when the weather conditions dictate, mostly when the temperature is predicted to be below a certain level. When spreading for multiple days no account is taken as to how much de-icer salt is left on the road.

The company was keen to develop an innovative method to measure the amount of di-icer salt on the road as the vehicle moves along, so it can be determined whether any more de-icer salt is required. Additionally, they wanted to develop a method of reporting this information back to the vehicle driver/equipment to enable them to alter the spread rate of de-icer.

Interface successfully matched Peacock Salt with Professor David Flynn from Heriot-Watt University, School of Engineering & Physical Sciences, to draw on his experience in research and knowledge exchange and guide the project. The project is funded by the Scottish Funding Council Follow-On Voucher, administered by Interface.

Napier University helped Scottish life sciences company, The Medical Device Co Ltd., save time and money trying to find a solution to an engineering problem it was trying to solve.

The Medical Device Co. Ltd managing director, John Targell said: “We specialise in helping clients in the plastics and disposable medical device industry take their ideas from initial concept to production.

The Business Challenge

“One of our clients wanted to do something out of our realm – in an area around thermodynamics – and luckily I met Dr. Siobhán Jordan, director of Interface at a seminar.”

After an introduction by Interface – the knowledge connection for business, The Medical Device Co. has been given help with technical challenges by Napier University engineering experts.

The Solution

As a result, the company has been told what they were trying to achieve would not be feasible as it defied the laws of physics!  However, this information allowed them to search for an alternative solution the company has now implemented.

John Targell continued: “This information was invaluable as letting us know that something is not possible saved us an immense amount of time and work.

“My previous experience with universities many years ago was that the collaboration process can be quite long-winded and the experts tend to be non-commercially focussed.  However, my recent experience has been excellent.  I’d certainly go to Interface again for help. They’ve made me realise that working with universities is a quick and straightforward process and ultimately the experience has saved us a lot of unnecessary work.”

Dr. Siobhan Jordan, director of Interface said: “This is an excellent example of one of the ways universities can help Scottish companies with their individual business challenges and Interface is keen to help business across all sectors and sizes access similar assistance.”

With a reputation spanning over 100 years, East Kilbride based Mentholatum are a recognised leader in the sale of Topical Pain Relief products.

The Business Challenge

Looking to diversify into the skincare market the company had developed a new range of skincare cosmetic products based on novel ingredients for the treatment of acne. Requiring academic analysis to be carried out on their range before they could be taken to market, the company was referred to Interface by Scottish Enterprise. They needed to gauge performance and efficacy in the key areas of:

The Solution

Following a full search of the academic base in Scotland, Interface introduced the company to Dr Richard Weller at the University of Edinburgh, who had relevant industry experience.
Leading the eight week clinical protocol study on the OXY range, Dr Weller conducted a full analysis report and published a white paper on the results, both of which have proven invaluable to Metholatum.

As Colin Brown, Director of Research and Quality Development at the company explains:

The introduction from Interface to the University of Edinburgh has been invaluable for the launch of our Oxy range for the spot prone skin market. The increased credibility we have received from working with the University and with Dr Weller has also improved our opportunities to gain increased  market share in the healthcare/personal care market.

The collaboration was also beneficial to the University in terms of highlighting the scope of their research to the wider business world, as Dr Weller comments:

The Mentholatum consultancy work has been very successful. We conducted a full clinical trial of its anti-spot products. To date, this work has gained considerable interest in two major British dermatology journals, and I suspect it will gain additional favourable media attention.

Creating Sustained Relationships

So successful has this collaboration been that Mentholatum see the partnership of University and business as filled with potential for future projects. Colin explains further:

This initial introduction has opened many doors within the University and also the wider Scottish academic network. We envisage this partnership with the University of Edinburgh as being long term and see many mutual benefits from working together.

2016

Since this initial project for their OXY skincare range, the company have funded a three year SUPA (Scottish Universities Physics Alliance) PhD studentship which investigated the application of Magnetic Resonance Elastography.

They have also sponsored a second PhD studentship through SINAPSE, a consortium of six of Scotland’s top universities’ medical imaging groups, including the University of Stirling and the University of Dundee.
This Scottish imaging network is at the forefront of research in the field of brain imaging.

Looking to the future,  Mentholatum is now collaborating with the Department of Physics at the University of Edinburgh on a project which will support the measurement of the rheological properties of its products.

Canon Medical Research Europe Ltd (previously Toshiba Medical Visualization Systems Europe Ltd) in Edinburgh is a key part of Canon Medical Systems Corporation’s global R&D network and is responsible for the design and development of cutting edge products and technology for use in medical imaging equipment.

The Business Challenge
 

Keen to tap into the expertise available within academia, Canon Medical Research Europe Ltd became aware of Interface at an event and arranged further meetings to discuss the company’s research and development requirements.

A specification was agreed and Interface undertook an expertise search for potential academic collaborators.

Ian Poole, Senior Scientist commented, “Interface offers companies access to a diverse network of world class expertise and plays a vital role in facilitating the partnerships.”

Interface identified the knowledge and facilities required within the SINAPSE POOL.
SINAPSE, the Scottish imaging network, is at the forefront of research in the field of brain imaging and brings together six of Scotland’s top universities – Aberdeen, Dundee, Edinburgh, Glasgow, St Andrews and Stirling.

Canon Medical Research Europe Ltd recognised the opportunity to capitalise on the extensive expertise within SINAPSE and was keen work with the group.

The Solution

Interface worked with SINAPSE and Canon Medical Research Europe Ltd to develop a successful Staff Exchange Programme with the University of Edinburgh and the University of Aberdeen.

Both parties have experienced significant benefits from this collaboration. The programme is a true example of successful knowledge exchange between academia which involves Canon Medical Research Europe Ltd employees spending time in a clinical environment and SINAPSE researchers and students spending time at the company premises embedded in an industrial environment.

Canon Medical Research Europe Ltd were able to explore with researchers the different technologies, techniques and approaches which can be used to develop images that may result in new or improved clinical diagnosis. The programme also provides university researchers with the opportunity to see how their research can be transformed into marketable products within an industry environment, building awareness of the tough requirements involved with commercial software. In addition the programme acts as a catalyst for innovation within Canon Medical Research Europe Ltd in providing an environment which is conducive to exploring new ideas.

Two Engineering Students at the University of Edinburgh also undertook placement at Canon Medical Research Europe Ltd.

The Future

The initial partnership between SINAPSE and Canon Medical Research Europe Ltd continues to flourish and has led to discussions regarding a larger collaboration which will build on the current project. The company has also announced its decision to launch a major new R&D programme in healthcare imaging informatics at its Edinburgh facility.

Ken Sutherland, Director of R&D at Canon Medical Research Europe Ltd’s Edinburgh facility commented, “Its great that we can tap into some of the first class academic research going on here in Scotland and at the same time play a useful role by sifting and highlighting those aspects of research that look most promising in terms of commercially viable innovation”.

Dr. Siobhán Jordan, Director at Interface commented, “The Staff Exchange Programme further demonstrates the importance and potential benefits of business and academia working in partnership. I am sure the recent news announced by Canon Medical Research Europe Ltd will present future potential collaborative opportunities between the two networks.”